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S U M M A R Y
Introduction: The monitoring of pre-antiretroviral therapy (pre-ART) is a key indicator of HIV quality of
care. This study investigated the association of an electronic medical record system (EMR) with
adherence to pre-ART guidelines in rural HIV clinics in Kenya.
Methods: A retrospective study was carried out to assess the quality of pre-ART care using three
indicators: (1) the performance of a baseline CD4 test, (2) time from enrollment in care to ﬁrst CD4 test,
and (3) time from baseline CD4 to second CD4 test. A comparison of these indicators was made pre and
post the introduction of an EMR system in 17 rural HIV clinics.
Results: A total of 18 523 patients were receiving pre-ART care, of whom 38.8% in the paper group had
had at least one CD4 test compared to 53.4% in the EMR group (p < 0.001). The adjusted odds of
performing a CD4 test in clinics using an EMR was 1.59 (95% conﬁdence interval 1.49–1.69). The median
time from enrolment into HIV care to ﬁrst CD4 test was 1.40 months (interquartile range (IQR) 0.47–
4.87) for paper vs. 0.93 months (IQR 0.43–3.37) for EMR. The median time from baseline to ﬁrst CD4
follow-up was 7.5 months (IQR 5.97–10.73) for paper and 6.53 months (IQR 5.57–7.87) for EMR.
Conclusion: The use of the EMR system was associated with better compliance to HIV guidelines for pre-
ART care. EMRs have a potential positive impact on quality of care for HIV patients in resource-
constrained settings.
Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access
article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
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Nearly two-thirds of the 34 million persons infected with HIV
globally live in Sub-Saharan Africa (SSA).1 As of December 2011,
70% of the 1.7 million HIV-related deaths occurred in SSA.2 The
high volume of patients in an environment that lacks adequate
skilled human resources and equipment, adds to the dire need to
invent ways to improve the quality of care for those infected with
HIV. Despite the availability of diagnostic testing for HIV and the
availability of highly active antiretroviral therapy (ART) since the
mid 1990s, early mortality remains high among patients who§ Disclaimer: The ﬁndings and conclusions in this paper are those of the authors
and do not necessarily represent the ofﬁcial position of the US Centers for Disease
Control and Prevention or the Government of Kenya.
* Corresponding author. Tel.: +254 20 286 7000; fax: +254 20 271 4745.
E-mail address: toluoch@cdc.gov (T. Oluoch).
http://dx.doi.org/10.1016/j.ijid.2014.06.004
1201-9712/Published by Elsevier Ltd on behalf of International Society for Infectious
creativecommons.org/licenses/by-nc-sa/3.0/).access ART with advanced symptomatic disease and low baseline
CD4.3,4 Effective pre-ART patient monitoring and timely initiation
of ART can potentially reduce HIV-related mortality.5 The
2010 revision of the World Health Organization (WHO) guidelines
on ART for HIV infection recommend using CD4 cell counts to
monitor pre-ART care and determine patient eligibility for ART
initiation.6 Although the 2013 revision of the WHO guidelines
recommending the use of viral load for patient monitoring were
released in July 2013,7 many countries are yet to adopt them.
Various studies have shown the beneﬁts of electronic medical
record (EMR) systems in delivering quality health care for chronic
illnesses.8–10 EMRs can be integrated into clinical practice to
enhance guideline adherence. Despite the evidence of the beneﬁts
of EMRs, many health facilities that offer HIV care and treatment in
SSA use paper-based records for patient data.11 As the number of
enrolled patients increases against a relatively ﬁxed number of
overworked health workers, the paper records become more prone Diseases. This is an open access article under the CC BY-NC-SA license (http://
T. Oluoch et al. / International Journal of Infectious Diseases 33 (2015) 109–113110to error, less efﬁcient, and ineffective in managing the complex
longitudinal patient data. This situation can potentially compro-
mise the quality of information used for patient care and thereby
negatively affect patient outcomes. Due to these considerations, a
number of health facilities in SSA are transitioning practice from
the use of paper records to EMRs in order to improve patient
monitoring and hence quality of care.10
The Kenyan Ministries of Health (MOH) and the US President’s
Emergency Plan for AIDS Relief (PEPFAR) have provided resources
for the national rollout of EMRs at HIV, tuberculosis, and maternal
and child health (MCH) clinics to improve data management for
clinical decision-making and reporting.
The aim of this study was to assess the effect of the change from
a paper-based to an electronic-based medical record system on
CD4 testing among HIV-infected persons in the pre-ART care
period.
2. Methods
We conducted a retrospective study to compare quality of care
indicators before and after the introduction of an EMR system at
17 health facilities providing HIV care and treatment services in
Nyanza Province, western Kenya. Study participants were patients
aged 2 years and older receiving HIV care at the participating
clinics, since the Kenyan HIV guidelines require that all children
under 2 years of age should initiate ART irrespective of their
immunological status. All the clinics had used paper-based records
before transitioning to electronic records at varying times from
January 2009 to February 2012.
2.1. Study setting
Nyanza Province has the highest HIV burden among Kenya’s
eight provinces, with a prevalence of 14.9%; it is home to about a
third of all HIV-infected persons in Kenya.12 EMRs were installed at
17 health facilities that had electricity and adequate security for
computers. The 17 clinics, which were providing HIV care and
treatment to about 39 203 active patients as of September 2012,
(PEPFAR semi-annual report for Kenya) are all located in rural
settings and encounter common challenges including inadequate
stafﬁng and weak infrastructure; the latter includes frequent
electric power interruptions and unreliable Internet access. The
studied facilities fall into three categories, as established by the
Government of Kenya, namely: district hospitals (n = 4), which are
level 4 (headed by a physician and providing both inpatient and
outpatient services); health centers (n = 11), which are level 3
(headed by a clinical ofﬁcer who is equivalent to a physician
assistant; these provide a limited number of services compared to
district hospitals); and dispensaries (n = 2), which are level 2
(headed by a nurse and providing only limited outpatient services).
2.2. Pre-ART care
Pre-ART care is provided during the period between a
conﬁrmed HIV-positive test and eligibility for ART initiation based
on Kenyan ART guidelines. Pre-ART care is offered at no cost to the
patient in many SSA countries. During the pre-ART care period,
HIV-infected patients receive a range of clinical services, including
the provision of co-trimoxazole prophylaxis, multivitamins,
screening for TB and other opportunistic infections, and routine
laboratory monitoring; key among these are CD4 cell count
measurements every 6 months and viral load tests. The CD4 cell
count serves as the most important laboratory indicator of the
degree of immunosuppression among HIV patients and is the most
important prognosis indicator for patients starting ART.3,4,13 The
CD4 test is now widely available in health facilities in SSA for theroutine monitoring of HIV disease progression and response to
treatment.
2.3. Paper-based patient monitoring system
The paper-based system entailed the recording of patient
details on an MOH-approved Comprehensive Care Clinic Card
(MOH 257) (Appendix). MOH 257 holds demographic and contact
details of the patient, treatment support data, HIV testing and
treatment history, allergies, HIV treatment eligibility and regimen
(ﬁrst- or second-line), vital signs, treatment outcomes, laboratory
results including CD4, co-infections, and an appointment date for
the next visit. Observations for each visit are recorded in a single
column on a paper chart (see Appendix).
Scheduling patient visits for each clinic day was done manu-
ally from the MOH 257 where the follow-up visit date was
recorded. Analyses such as tracking of patient clinic visit
appointments, trends in measurements such as vital signs and
treatment progress including CD4 cell counts, statistical summa-
ries for hospital administration use, and MOH reporting were all
conducted manually. Clinicians reviewed the individual patient’s
treatment history based on ﬁled paper notes during routine clinic
visits.
2.4. Electronic medical record (EMR) system
The EMR system rolled-out in the 17 facilities is called the
Comprehensive Care Centre Patient Application Database (C-PAD)
and was developed in 2007.
Data management entails clinicians recording information on
paper forms (MOH 257), as was the case for the paper-based
system, followed by data entry by a data clerk into the EMR on the
same day as the clinic visit or the next day. Mandatory variables
such as demographic data, vital signs, medications, and key
laboratory measurements must be entered into the computer for
the continuation of system operation. It takes about 10 min to
enter the records of a new patient and about 5 min to update the
records of a revisit patient if all required information is available.
Data clerks make immediate follow-up with the clinicians to
provide any missing data. Weekly reviews of EMR-generated
patient summary reports are used to ﬂag patients with conditions
that need follow-up – for example, patients with no baseline CD4
result or those whose follow-up CD4 tests are overdue. Data entry
by data clerks is common practice in many SSA countries as clinics
transition from the use of paper to electronic systems. Clinicians
interact with the EMRs through the weekly patient summary
reports or by directly reviewing individual patient data on the EMR
in addition to the paper records.
For this study, pre-EMR data from the paper forms (MOH 257)
were entered retrospectively for all patients who initiated
treatment prior to the installation of the EMR system, and
compared to electronic data for patients enrolled in HIV care
after the installation of the EMR.
2.5. Outcome measures
We assessed the effect of EMR use on the following factors,
which are key in pre-ART care: (1) performing a baseline CD4 test,
(2) time from enrolment into HIV care to the ﬁrst (baseline) CD4
test, and (3) time from the ﬁrst to the second CD4 test.
Each patient enrolled in HIV care should undergo baseline CD4
testing. The shorter the time from enrolment into HIV care to
baseline CD4 testing, the better the compliance with HIV treatment
guidelines.13 According to the HIV treatment guidelines, a repeat
CD4 test should be performed for every patient at least once every
6 months. For each site, the date of C-PAD installation was used to
Table 1
Characteristics of pre-ART patients receiving HIV care during the paper and EMR
phases at 17 health facilities in Siaya County, western Kenya
Paper, n (%) EMR, n (%) Total
Number of
patients (n)
15 476 3047 18 523
Sex
Male 4938 (31.9%) 1056 (34.7%) 5994
Female 10538 (68.1%) 1991 (65.3%) 12529
Median age,
years
28.9 28.1 28.7
WHO stage
1 4408 (29.9%) 1239 (46.3%) 5647
2 4197 (28.5%) 852 (31.8%) 5049
3 5763 (39.1%) 527 (19.7%) 6290
4 371 (2.5%) 58 (2.2%) 429
Recorded CD4
results
6001 (38.8%) 1626 (53.4%) 7627 (41.2%)
MOH level
(clinic type)
2 664 (4.3%) 98 (3.2%) 762
3 2799 (18.1%) 460 (15.1%) 3259
4 12 013 (77.6%) 2489 (81.7%) 14502
Mean duration
of data collection
(months)
55.3 14.1 35.2
Pre-ART, pre-antiretroviral therapy; EMR, electronic medical records; WHO, World
Health Organization; MOH, Ministries of Health.
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Figure 1. Time from enrolment into HIV care to ﬁrst CD4 test among pre-ART
patients.
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EMR-based data management.
2.6. Statistical analysis
Data for each visit were ordered by visit date; records with a
CD4 count but with no CD4 date, had the CD4 date imputed using
the clinic appointment date prior to that corresponding to the CD4
result in the database.
We used descriptive statistics to summarize continuous vari-
ables using the median and interquartile range (IQR). Logistic
regression was used to calculate the odds ratio (OR) and the adjusted
odds ratio (aOR) to test for any association between EMR use and the
performance of baseline CD4 tests. Cox proportional hazards
regression was used to calculate hazard ratios (HR) and adjusted
hazard ratios (aHR) to test the associations between EMR use and the
time-based outcomes (time from enrolment in HIV care to ﬁrst CD4
test, and time from ﬁrst to second CD4 test). In the multivariate
analyses (Cox proportional hazard and logistic regression), we
adjusted for age and sex of the patient, year of change of treatment
guidelines, and the level of the health facility, and used the paper
system as the reference group. Kaplan–Meier survival graphs were
used to visually present the comparison of time to event for the two
time-based outcomes. For time-based outcomes, records that did
not have a CD4 test result were censored on the date of the last visit.
The log rank test of equality was used to test for statistical
differences in the rate of occurrence of the time-based outcomes in
the paper and EMR groups. The survivor function measurement was
used to calculate the median time to event and the IQR. Pearson’s
Chi-square test was used to compare proportions and to calculate
associated p-values. The generalized estimating equations (GEE)
method was used to adjust for intra-facility correlation. Statistical
analysis was conducted using Stata version 12.1.
2.7. Ethical considerations
The study was approved by the US Centers for Disease Control
and Prevention (CDC) and Kenya Medical Research Institute
(KEMRI) institutional review boards. Prior to analysis, individual
patient data were de-identiﬁed by the KEMRI staff responsible for
primary data collection.
3. Results
A total of 37 851 patients aged 2 years and older were enrolled at
the clinics, of whom 18 523 (48.9%) were receiving pre-ART care as
they were not yet eligible for ART based on the national guidelines.
This excluded 2414 patients who had transferred in from other
clinics. The pre-ART care patients consisted of 12 529 females (67%)
and 5994 males (33%). Overall, 15 476 patients were enrolled in HIV
care before the implementation of the EMR (paper group), while
3047 were enrolled after EMR implementation (EMR group). The
median age of patients at enrolment in the paper group was
28.9 years (IQR 22.8–37.2) and in the EMR group was 28.1 years (IQR
23.0–35.9). Table 1 shows the characteristics of the pre-ART
patients.
3.1. Association between EMR use and performance of the baseline
CD4 test
Among the 18 523 patients receiving pre-ART care, 7627
(41.2%) had at least one CD4 test result recorded, while 10 896
(59%) did not have any CD4 test results. Among the pre-ART care
patients, 6001 (38.8%) in the paper group had at least one CD4 test,
while 1626 (53.4%) in the EMR group had at least one CD4 test.
These included 15.7% (n = 1195) and 9.2% (n = 150) of patients withimputed CD4 test dates in the paper and EMR groups, respectively
(patients who had a CD4 result recorded but missing the date of
CD4 test). In the bivariate analysis, the odds of performing the
baseline CD4 test was 57% higher using the EMR compared to the
paper system (OR 1.57; 95% conﬁdence interval (CI) 1.49–1.66).
After adjusting for patient age and sex, level of health facility, and
year of change of treatment guidelines, the use of EMR was
independently associated with 59% higher odds of ever performing
the baseline CD4 test compared to the paper system (aOR 1.59, 95%
CI 1.49–1.69).
3.2. Time from enrolment into HIV care to ﬁrst CD4 test among pre-
ART patients
Among the pre-ART patients who had at least one CD4 test, the
median time from enrolment into HIV care to ﬁrst CD4 test was
1.40 months (IQR 0.47–4.87) for paper vs. 0.93 months (IQR 0.43–
3.37) for EMR. Figure 1 shows the time from enrolment in HIV care
to baseline CD4 test. The proportion of patients with baseline CD4
tests conducted within 3 months of enrolment was 64.8% (95% CI
63.1–66.5) for the paper-based system vs. 74.1% (95% CI 70.5–77.5)
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Figure 2. Time from ﬁrst to second CD4 test among pre-ART HIV care patients.
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indicated that EMR use was associated with a 57% higher hazard of
conducting a CD4 test compared to the paper system (HR 1.57; 95%
CI 1.26–1.95). After adjusting for age and sex of the patient, level of
health facility, and year of change of treatment guidelines, EMR use
was associated with a hazard ratio of 1.49 (95% CI 1.17–1.88).
3.3. Time from ﬁrst CD4 test to second CD4 test among pre-ART
patients
Among the 18 523 pre-ART patients, 2863 (15.5%) had had at
least two CD4 tests done; 2295 (14.8%) were in the paper group,
while 568 (18.6%) were in the EMR group. The median time from
baseline to ﬁrst follow-up CD4 test was 7.5 months (IQR 5.97–
10.73) for paper and 6.53 months (IQR 5.57–7.87) for EMR. Figure 2
shows the Kaplan–Meier curves for the time from ﬁrst to second
CD4 test. Six months after the ﬁrst CD4 test, 25.7% (95% CI 24.0–
27.5) of patients had had a second CD4 test for the paper-based
system compared to 35.0% (95% CI 31.2–39.1) using the EMR
system. The hazard ratio of conducting a second CD4 test was 1.78
(95% CI 1.30–2.46). After adjusting for patient age and sex, level of
health facility, and year of change of treatment guidelines, EMR use
was associated with a 49% higher hazard of conducting a second
CD4 test (aHR 2.09; 95% CI 1.41–3.09).
Among the patients enrolled on pre-ART HIV care, 1591 (8.6%)
and 914 (4.9%) had at least three and four CD4 tests, respectively.
The intervals between the successive tests were comparable to the
time from ﬁrst to second CD4 test.
4. Discussion
EMR use was associated with better adherence to the pre-ART
care guidelines in all three of the outcome measures. The clinical
guidelines13 require that a baseline CD4 test be conducted at
enrolment; however, only 41% of the patients had a baseline CD4
recorded. Among those with a recorded baseline CD4, two-thirds of
patients in the paper system and three-quarters in the EMR had a
baseline CD4 test 3 months after enrolment into pre-ART care. The
EMR was associated with a 59% increase in the odds of performing
a baseline CD4 test. There was a signiﬁcant reduction in time from
enrolment into pre-ART care to the ﬁrst CD4 test. EMR use was
associated with a 47% higher hazard of conducting a baseline CD4
test. The proportion of patients who had had a second CD4 test
6 months after the ﬁrst one was low. Only 26% (paper) and 35%
(EMR) of patients had had a second CD4 at 6 months as required in
the ART guidelines. The median time from ﬁrst to second CD4 test
using the EMR was closer to the recommended 6 months compared
to the paper system.Although not reported in the results section, we found data
quality to be better in the EMR compared to the paper system. For
example, key data elements such as date of CD4 test and CD4
results were three times more likely to be missing in the paper
system compared to the EMR. This could be attributed to the fact
that the EMR contains mandatory ﬁelds that must be entered,
resulting in fewer missing values. Data clerks also add a layer of
data quality checking during data entry into the EMR and consult
with clinicians when they encounter missing values. In some
cases, results are lost between the laboratory and the data entry
room. In such cases, even the EMR was not able to improve the
completeness of recorded data and this could have contributed to
the missing CD4 results as reported in this paper. Some CD4 tests,
mainly in the EMR group, were conducted earlier than the
6 months stipulated in the guidelines. An earlier CD4 test can be
ordered if a clinician suspects HIV treatment failure or if a previous
CD4 test was conducted when a patient had an acute illness.
The ﬁndings of our study are consistent with those of studies by
Williams and Boren,10 Alamo et al.,14 and Were et al.,15 which were
also conducted in resource-constrained settings. These studies
showed that EMR use was associated with a reduction in time to
various events such as patient waiting time, time spent by clinicians
attending to patients, and time to order a laboratory test in HIV
clinics. The three studies above were each conducted in a single
clinic, with a relatively small sample size compared to our study.
One of the key strengths of the present study is that the data
were collected from 17 clinics thereby providing a large and
general patient population. All the clinics use the same guide-
lines13 and the same EMR, hence the patient management
procedures, administrative procedures, drug regimens, and
laboratory investigations are standardized.
Our study was limited by some factors. EMRs are still not fully
used at the point of care, mainly due to infrastructure problems such
as a lack of reliable electric power. The clinics have, however, made
every effort to ensure that the time between the consultation and the
entry of the records into the computer is as short as possible so that
clinical staff can provide any missing data or act on incorrect data
promptly. We also dropped records that did not have an enrolment
date recorded and imputed CD4 dates in cases where CD4 results
were recorded but the CD4 test date was missing. Nearly 60% of the
patients did not have a CD4 test result recorded. This was due to a
combination of data quality problems, missed orders, and missing or
lost results from the laboratory. Other contributing factors could be
limited access to CD4 tests in rural areas, where the study sites are
located, equipment breakdown, stock out of test reagents, inade-
quate staff in the laboratory, and clinicians being unaware of the
guidelines. Due to the retrospective nature of our study, we were not
able to pinpoint the contribution of each of the aforementioned
reasons to missing CD4 test results. We were also unable to quantify
the fraction of missing data that required additional consultation
between the data clerk and clinician. However, the data clerks and
clinicians indicated that the missing information that required
consultations reduced with time. Additionally, due to the retrospec-
tive, observational, before-and-after design of this study we were
not able to determine a cause and effect relationship between the
use of the EMR and the outcome variables. Some of the outcomes
could have been effected temporal changes, such as improved
practice, delivery of supplies, and improved laboratory equipment.
Further investigations on the strength of associations between EMR
use and the outcomes described in this study need to be assessed
through a prospective randomized controlled trial.
With regard to the implications of the study, the EMR seems to
have improved quality of patient care. As many health care
systems in developing countries increase investment in these
technologies in order to provide quality care to the increasing
volumes of HIV patients, there is need for the quantiﬁcation of
T. Oluoch et al. / International Journal of Infectious Diseases 33 (2015) 109–113 113empirical evidence of the impact of such interventions on quality
of care. In a competitive funding environment, only technologies
that have been shown to be positively associated with adherence
to guidelines and better quality of care justify funding. This study
therefore adds to the body of knowledge that will inform the
deployment of EMRs in resource-limited settings like Kenya.
Additionally, the data presented in this study show that there is
need to improve the timeliness of conducting CD4 tests.
Further work on evaluation of the use of clinical decision
support functionality of an EMR on compliance with pre-ART
guidelines is needed to provide a more complete picture of the
effect of EMRs. Speciﬁcally, there is need to assess whether the
beneﬁts of point-of-care use of EMRs with decision support
systems in resource-limited settings can be similar to those
documented in developed countries.16,17
In conclusion, our study demonstrated the use of the EMR to be
positively associated with enhanced compliance with key quality
indicators for pre-ART care, as required by the HIV treatment
guidelines. EMRs have a potential positive impact on quality of care
for HIV patients in the resource-constrained setting. However,
there is still the need for much greater improvement.
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